Birgit C Schultes Receives Stock Award at Intellia Therapeutics Inc (NTLA) — SEC Form 4, Mar 03, 2026

SEC Form 4 · No Market Transaction

Stock Award

Compensation grant — no market purchase or sale.

Reporting Owner

Birgit C Schultes

EVP

TXN 2026-03-01 · FILED 2026-03-03

Equity Position 138K sh 98,533 → 137,733

Equity Change +39.8% shares held after vs before

Filing Lag 2 business days within 2-day SEC deadline

Form 4 · Statement of Changes in Beneficial Ownership

Intellia Therapeutics Inc

NTLA CIK 0001652130

Reporting Owner

Name	Relationship
Birgit C Schultes CIK 0002051419	EVP

Birgit C Schultes at Intellia Therapeutics Inc Full insider history

Bought (12 mo) —

Sold (12 mo) $78,359

More from this insider at Intellia Therapeutics Inc

Non-Derivative Securities Transactions

Title	Date	Type	Shares	Price	Net Total	Post-Txn	Ownership
Common StockF1	2026-03-01	A - Award/Grant	39,200 A	$0.00	—	137,733	Direct

Derivative Securities Transactions

Title	Strike	Date	Type	Shares	Price	Expiration	Underlying	Ownership
Stock Option (right to buy)F2	$13.78	2026-03-01	A - Award/Grant	56,000 A	$0.00	2036-02-29	56,000 Common Stock	Direct

Footnotes (2)

F1: Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit. Show more
F2: This option was granted on March 1, 2026 with respect to shares of Common Stock, with 33% vesting on January 1, 2027 and the remaining 67% vesting in 24 substantially equal monthly installments thereafter. Show more

Institutional Holders

Largest by reported value

5%+ Holders · 13D/G 5 filers

Latest Schedule 13D/G per filer; stakes the filer reported closed are left out.

Other insiders at Intellia Therapeutics Inc

GET /v1/forms/4/0001193125-26-088251 API docs